← Evidence map

ArticleBiochemical pharmacology2014

Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.

Yi-Jun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

30 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 24937702